This site looks better in landscape mode! Turn your device on its side!

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 50%

Over half of people diagnosed with knee osteoarthritis are under 65 years of age

NEWS

APPA reduces senescence & reactive oxygen species production

Read More

NEWS

New studies suggests APPA protects against joint damage

Read More

NEWS

APPA Phase II human study completes ahead of schedule

Read More